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Table I. Access vs number readmissions per access group
Access
Patients
(No.)
Days
1-15 16-30 31-90 Total
AVF  AVG 175 10 (3)a 24 (3) 54 (5) 88 (11)
TDC 125 11 (2) 12 (1) 49 (6) 62 (9)
aParenthesis for admissions directly related to access (ex: failure, thrombosis,
infection).
Methods: This was a retrospective analysis of 300 patients between
March 2009 and July 2010 already undergoing hemodialysis via TDC, AVF,
or AVG for readmissions at 15, 30 and 90 days.
Results: There was no statistically significant difference in the 15-, 30-,
and 90-day readmission rate in the patients with TDCs compared with
permanent access (Table I and Table II).
Conclusions: TDCs were shown to be as safe and cost-effective as
permanent access during these time periods. Shortening hospital stay by
discharging patients with TDCs and electively placing permanent access
could result in better outcomes and significant cost savings.
Table II. Negative binomial regression analysis of readmissions of TDCs
vs permanent access
Time period RR (95% CI) P
1 to 15 days 1.38 (0.56-3.37) .482
16 to 30 days 0.67 (0.33-1.35) .261
31 to 90 days 1.24 (0.81-1.91) .316
Overall 1.09 (0.75-1.58) .637
CI, Confidence interval; RR, risk ratio.
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Objective(s): Several authorities have proposed stenting of the
superior mesenteric artery (SMA)/celiac arteries (CA) as the primary
treatment for patients with chronic mesenteric ischemia. However, most
of these reports had a small sample size and short follow-up period. This
is one of the largest studies to date to analyze early and late outcomes of
stenting of SMA/CA stenosis.
Methods: During a 10-year period, 83 patients were treated and
underwent clinical follow-up and duplex ultrasound examinations to
evaluate long-term patency. A Kaplan-Meier life-table analysis was used
to estimate freedom from in-stent stenosis and late symptoms and
survival rates.
Results: Outcomes for 54 SMAs and 51 CA were analyzed. The initial
technical and clinical success rates were 97% and 96%, respectively, with 2% periop-
erative morbidity and 2% mortality. The primary late clinical success rate was 59%
and the late70% in-stent stenosis ratewas 54% at amean follow-up of 31months
(range, 1-124months).Rates for freedomfrom late recurrent symptomswere83%,
77%,70%,70%, and65%at1,2,3,4, and5years, respectively.Primarypatency rates
of the whole series were 68%, 48%, 36%, 26%, and 18% at 1, 2, 3, 4, and 5 years,
respectively, and the assisted primary patency rates were 79%, 60%, 51%, 41%, and
32%. The primary patency rates for SMA at 1, 2, 3, 4, and 5 years were 68%, 45%,
31%,24%, and16%, respectively, and theassistedprimary rateswere79%,62%,50%,
39%, and 28%. The primary patency rates for CA were 68%, 50%, 40%, 29%, and
21%, and the assisted primary rates were 79%, 58%, 52%, 42%, and 36% for 1, 2, 3,
4, and 5 years, respectively. There were no significant differences in primary or
assisted primary patency between SMA (P  .5605) or CA (P  0.5782; Fig).
Secondary intervention was done in 30% of the series.
Conclusions: Stenting of SMA/CA stenosis has a high technical and
early clinical success rates, with a satisfactory late clinical outcome;
however, it is associated with high rates of late in-stent stenosis and
intervention.
Table.
Time,
months At risk
SMA
Cum APP SE At risk
Celiac
Cum APP SE
0 51 0.9608 0.0272 54 0.9815 0.0183
1 38 0.9608 0.0272 46 0.9601 0.0277
6 33 0.9074 0.0448 39 0.8926 0.0456
12 26 0.7864 0.0684 32 0.7926 0.0621
24 19 0.6209 0.0852 19 0.5845 0.082
36 11 0.4975 0.0943 13 0.5158 0.0856
48 8 0.3918 0.0998 9 0.4232 0.0925
60 3 0.2799 0.0978 6 0.3627 0.0971
Endovascular Aneurysm Repair in the Elderly: Trends and Outcomes
From the National Inpatient Sample
Nchang Azefor, MD,1 Brian D. Park, MD,1 Chun-Chih Huang, PhD,1
Cameron Akbari, MD,1 Frederick Beavers, MD,1 David Deaton, MD,2
Robyn Macsata, MD,3 Sean O’Donnell, MD,1 Susanna Shin, MD,1 John
Ricotta, MD1. 1The Washington Hospital Center, the 2Georgetown Uni-
versityHospital, and the 3Washington VAMedical Center,Washington, DC
Objective(s): This study used the a nationwide data set to identify
trends in endovascular abdomianal aortic aneurysm (AAA) repair (EVAR)
utilization and outcomes during a 5-year period.
Methods: The Nationwide Inpatient Sample database was queried
for the years 2005 to 2009. Number of EVAR cases, ratio of EVAR/open
repair (OR), major clinical outcomes, hospital costs and discharge status
were analyzed by decade. Interval data were compared with analysis of
variance and proportions via 2 tests.
Results: There were 174,714 AAA repairs (124,869 EVAR) identi-
fied. The ratio of EVAR/OR increased with increasing age. Between
2005 and 2009, the number of AAA repairs in the elderly increased by
21% (7179 vs 8554), and EVAR in patients aged 80 years increased by
50% (5057 vs 7650 P  .05). In 2009, 85% of AAA repairs in patients
aged 80 years were EVAR, and 25% of EVAR were performed in
patients aged 80 years, equivalent to age 60-69 years. The in-hospital
mortality rate remained acceptable in all age groups. EVAR-associated
mortality, length of stay, hospital costs, and discharge to skilled nursing
facility increased with each successive decade of life (P  .05). Postop-
erative myocardial infarction and acute renal failure also increased with
increasing age (P  .05). EVAR results by decade are presented in the
Table.
Conclusion: One-quarter of EVAR are performed in patients aged
80 years based on low mortality rates. There is an age-dependent
increase in death, complications, hospital costs, and discharge to ex-
tended care facilities. Such factors and long-term risk of aneurysm-related
death should be considered when evaluating the appropriateness of
elective aneurysm repair in the elderly.Fig.
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Table. EVAR results by decade
Variable
Age group, years
60-69 70-79 80-89 90
Patients, No. 33,629 56,783 32,493 1964
Mortality, % 0.46 .70 1.56 2.49
Average length of
stay, days 2.7 3.1 3.6 4.6
Average hospital
cost, $ 26,399 27,350 28,490 30,741
Discharge to SNF,
% 2.19 5.21 11.12 22.29
SNF, Skilled nursing facility.
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Objective(s): Although chronic obstructive pulmonary disease
(COPD) has been implicated as a risk factor for aneurysm rupture, its
impact on surgical repair remains undefined. Consequently, variation in
practice persists regarding patient selection and surgical management.
The purpose of this study was to analyze the effect of oxygen-dependent
COPD on patients undergoing abdominal aortic aneurysm (AAA) repair.
Methods: We reviewed a prospective regional registry of 3455
patients undergoing elective open and endovascular AAA repair from 23
centers in New England from 2003 to 2011. COPD was categorized as
none, mild (non-O2 dependent), and severe (O2 dependent). End points
included in-hospital death, pulmonary complications, major postopera-
tive adverse events (MAEs), extubation in the operating room, and
5-year survival. Survival was determined using life-table analysis. Predic-
tors of in-hospital and long-term mortality were determined by multivar-
iate logistic regression and Cox proportional hazards analysis.
Results: During the study interval, 2043 patients underwent EVAR
and 1412 underwent open AAA (oAAA) with a nearly equal prevalence of
COPD (35% EVAR vs 36% oAAA). Severe COPD was associated with
significantly increased in-hospital death, pulmonary complications, and
MAE (Fig) and with significantly decreased operating room extubation
among patients undergoing EVAR and oAAA. Five-year survival was
significantly diminished among all COPD patients (none, 78%; mild,
72%; severe, 42%; P  .001) undergoing AAA repair. By multivariate
analysis, O2-dependent COPD was independently associated with in-
hospital death (odds ratio, 2.02; 95% confidence interval, 1.0-4.0; P 
.04) and diminished 5-year survival (hazard ratio, 3.02; 95% confidence
interval, 2.2-4.1; P  .001).
Conclusions: Severe COPD is associated with increased pulmonary
complications, overall MAE, and diminished long-term survival among
patients undergoing AAA repair. Accordingly, aneurysm repair in patients
with COPD warrants extremely prudent risk/benefit assessment in the
setting of increased rupture risk but decreased 5-year survival.
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Objective(s): Type II endoleaks with growing aneurysm sac 5 mm
after endovascular aneurysm repair require treatment. Different treatment
options have been reported. This study evaluated the use of an ethylene-vinyl
alcohol copolymer (Onyx) in an endovascular approach, hereby presenting
our midterm results in 10 patients with 13 type II endoleaks.
Methods: Between January 2010 and December 2011, 10 patients
with 13 persistent type II endoleaks leading to aneurysm growth 5 mm
were treated in our center using transarterial Onyx embolization by super-
selective cannulation of the endoleak with microcatheters. Technical success
was defined as transarterial Onyx deployment directly into the aneurysm sac.
Clinical success was defined as stable or shrinking axial aneurysmal diameter
during follow-up using computed tomography angiography.
Results: Technical success was achieved in 12 of 13 (92%) type II
endoleaks. Two patients underwent a staged procedure because of several
unconnected type II endoleaks. In one patient, a cannulation of the en-
doleak was not possible. Continued efforts lead to a rupture of the hypogas-
tric artery, which was treated by covered stent implantation. In one patient,
an extravasation of Onyx out of the aneurysm sack into the inferior vena cava
during the embolization process made a transvenous goosesnare maneuver
necessary to retrieve the dislocated copolymer. Yet, no further complications
were observed because the endoleak was occluded. In all patients with
successful embolization, the aneurysm sac remained stable or shrank within
a mean follow-up of 19.8 months (range, 3-31 months).
Conclusions:The use of Onyx in the endovascular treatment of type II
endoleaks after endovascular aneurysm repair is feasible. Although this field
has scarce published data, transarterial copolymer embolization seems to
have a higher success rate than direct puncture. Further studies are necessary
to evaluate the value of these different treatment modalities.
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Objective(s):Acutemesenteric ischemia (AMI) is a commonly fatal result of
inadequate bowel perfusion that requires immediate evaluation by vascular and
general surgeons.Treatmentoften involves vascular repair aswell as bowel resection
andpossible need for total parenteral nutrition (TPN). Fewdata exist regarding the
rates of bowel resection after endovascular vs open repair of AMI.
Methods: The Nationwide Inpatient Sample database was used to
identify admissions from 2005 to 2009 according to International Classifi-
cation of Diseases, 9th Clinical Modification codes correlating to AMI
(557.0) and a subsequent vascular intervention (39.26, 38.16, 38.06, 39.9,
99.10). Patient-level data and the need for bowel resection (45.6, 45.71-9,
45.8) or TPN (99.10) during same hospitalization were examined.
Results: From 2005 to 2009, 23,744 patients presented with AMI, and
4,665 patients (66.5% women; mean age, 67.6 years) underwent interventional
treatment. The proportion of treated patients undergoing vascular intervention
increased from11.4%in2005to19.0%in2009(P .001).Amongpatients treated
with vascular intervention, 514 (75.7%) underwent open surgery and 165 (24.3%)
underwent endovascular treatment. Severity of comorbidities, as measured by the
Charlson index, did not differ significantly between the treatment groups. During
the study period, 12.2% undergoing endovascular procedures required bowel
resection comparedwith 29.8% for open revascularization (P .001). Inweighted
averages, patients undergoing endovascular repair also required TPN less often
(16.7% vs 24.1%; P .049).
Conclusions: Among AMI patients undergoing revascularization, en-
dovascular treatment was associated with decreased rate of bowel resection
(12.2%) and need for TPN (16.7%). Further research is warranted to
determine if increased use of endovascular repair could improve gastrointes-
tinal outcomes among patients requiring vascular repair for AMI.
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